The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats.
Cheng Z Wang, Kenneth M Johnson
Neuropsychopharmacology May 2007 DOI: 10.1038/sj.npp.1301202 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental animal and in vitro study Peer reviewed |
|---|---|
| Population | Postnatal day 7 rats and organotypic corticostriatal slice cultures |
| Intervention | Phencyclidine (PCP) |
| Duration | Assessments from 2 to 24 hours after PCP treatment |
| Measures | caspase-3 enzymatic activity, cleaved caspase-3 immunoreactivity, silver staining, terminal deoxynucleotidyl transferase biotin-d-UTP nick-end labeling (TUNEL) |
| Key findings | PCP administration to postnatal day 7 rats caused dose-dependent caspase-3 activation in frontal cortex, striatum, and hippocampus, peaking 6-12 hours after treatment and preceding TUNEL-marked DNA damage by about 3 hours. A cell-permeable selective caspase-3 inhibitor blocked PCP-induced neuronal death in slices by 85%, which the authors say demonstrates that caspase-3 activation plays a necessary role in PCP-induced regionally selective neuronal death in the developing rat brain. |
Abstract
This study determined the role of caspase-3 in phencyclidine (PCP)-induced neurodegeneration in postnatal rats. PCP administration to postnatal day 7 rats induced a dose-dependent increase in caspase-3 enzymatic activity in frontal cortex, striatum, and hippocampus. Enzymatic activation was present at 4 h, peaked between 6 and 12 h, and disappeared by 24 h. Further, cleaved caspase-3-immunoreactive neurons were detected as early as 2 h in the cortex, and were found throughout the brain, including, in addition, the thalamus and striatum. Within the cingulate, frontal, parietal, and retrosplenial cortices, immunoreactivity was specific for layers II-IV (especially layer II). Neurons positive for both silver staining and terminal deoxynucleotidyl transferase biotin-d-UTP nick-end labeling (TUNEL) were found in the same brain regions and subregions. Double labeling experiments confirmed that cleaved caspase-3 and TUNEL were coexpressed in many neurons in all brain regions and subregions studied. Temporal studies revealed that procaspase-3 cleavage preceded TUNEL staining by about 3 h, with many neurons being positive for both caspase-3 and TUNEL 9 h after PCP treatment. In organotypic corticostriatal slices, PCP caused a concentration- and time-dependent cleavage of procaspase-3 that was also colocalized with TUNEL staining in layers II-IV of the parietal cortex. Caspase-3 activation again preceded PCP-induced DNA damage assessed by TUNEL. PCP-induced neuronal death in vitro as measured by TUNEL staining was blocked 85% by Ac-AAVALLPAVLLALLAPDEVD-CHO, a cell-permeable selective caspase-3 inhibitor. These data demonstrate that caspase-3 activation plays a necessary role in the regionally selective neuronal death induced by PCP in the developing rat brain.
Citations in the library
Cited by 8
- Qualitative and quantitative in silico toxicity profiling of "angel dust": phencyclidine (PCP) analogues as new psychoactive substances (3-HO-PCP, 3-MeO-PCP, 4-MeO-PCP, 3-HO-PCE, 3-MeO-PCE, 4-MeO-PCE). Archives of Toxicology December 8, 2025
- The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia. Pharmacology, Biochemistry, and Behavior December 2018
- α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels. Journal of Neuroscience Research December 2014
- Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology February 2010
- Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength. Journal of Neurochemistry May 2009
and 3 more in the library
Cites 5
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- Study of a New Schizophrenomimetic Drug—Sernyl Archives of Neurology And Psychiatry March 1, 1959
- The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochemical Pharmacology May 1, 2005
- Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. Journal of Neuroscience July 15, 1998
- Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science June 16, 1989